Presentation is loading. Please wait.

Presentation is loading. Please wait.

Management Team Dr Stephen Edwards: Commercial and Managing Director PhD Industrial Biotechnology, Knowledge Transfer Manager Professor Mathew Brown:

Similar presentations


Presentation on theme: "Management Team Dr Stephen Edwards: Commercial and Managing Director PhD Industrial Biotechnology, Knowledge Transfer Manager Professor Mathew Brown:"— Presentation transcript:

1

2 Management Team Dr Stephen Edwards: Commercial and Managing Director PhD Industrial Biotechnology, Knowledge Transfer Manager Professor Mathew Brown: Research and Development Director Professor of Cell Biology & Applied Virology Dr Amos Iorliam: Operations Director MBA Harvard University, LLP Ruth Kennedy-Walker: Finance Director MBA, FCA, Chartered accountant: PWC

3 COST OF PIPELINE CORROSION COST OF MIC £12.1 Billion £3.6 Billion Cost of Corrosion in the Oil Industry

4 Microbial Influenced Corrosion

5 Metabolites Microbial Influenced Corrosion

6 COST OF PIPELINE CORROSION COST OF MIC £12.1 Billion £3.6 Billion £1.9 Billion Cost of MIC in the Oil Industry

7 MIC Mitigation/Maintenance Dewatering Physical Cleaning (Pigging) Flushing/Addition of Biocides Introduction of Chemical Inhibitors Internal pipeline coatings

8 MIC Phage Therapy

9 Lab Scale Results:  Reduced Biofilm Formation by up to 20%  Reduced MIC Causing Bacteria by 60%  Reduced Corrosion by up to 25% Phage Therapy Vs. Biocides/Inhibitors Phage AdditionBiocide Addition

10 Market Opportunity £1.9 Billion p.a£475 Million p.a

11 Where We Have Come From? 200820092010201120122013 Investment Pitch 2/12/2013 Formation of Spin Out Company - Phage Off 1/4/2013 EPSRC Advanced Research Fellowship 1/9/2008 1/3/2013 - 1/3/2013 International Patents Filed in Target Nations 1/5/2013 - 1/5/2013 UK IP Granted 1/11/2010 - 1/11/2010 UK Priority Applications 16/9/2013 - 16/9/2013 IP License and Research Concordat Agreed with University 1/9/2011 - 1/9/2012 Phage Application Experiment 1/9/2009 - 1/9/2011 Development of Lab Scale Culture Techniques 1/9/2008 - 1/9/2010 Identification and Isolation of Major MIC causing Bacteria and Associated Phages

12 Business Strategy: Years 1 - 3 20132014201520162017 End of Year 3 1/1/2017 End of Year 2 1/1/2016 End of Year 1 1/1/2015 Investment Pitch 2/12/2013 Formation of Spin Out Company - Phage Off 1/4/2013 1/1/2014 - 1/1/2017 Continued R & D 1/1/2016 - 1/1/2017 Identify Potential Licensees/ Building Market Presence 1/7/2014 - 1/7/2016 Scale Up of Phage Application 1/7/2014 - 1/3/2017 Production of Phage Culture 1/1/2014 - 1/7/2014 Scale Up of Phage Culturing Techniques

13 Intellectual Property 20102011201220132014201520162017 End of Year 3 1/1/2017 End of Year 2 1/1/2016 End of Year 1 1/1/2015 Investment Pitch 2/12/2013 Formation of Spin Out Company - Phage Off 1/4/2013 1/12/2014 - 1/11/2016 Patents Granted in Target Nations 1/3/2013 - 1/3/2013 International Patents Filed in Target Nations 1/9/2011 - 1/9/2011 International PCT Applications 1/5/2013 - 1/5/2013 UK IP Granted 1/11/2010 - 1/11/2010 UK Priority Applications

14 Expenditure: Years 1 - 3

15 Projected Income: Years 4 - 10

16 Growth and Future Markets Gas Oil Wastewater Drinking water

17 Thank You


Download ppt "Management Team Dr Stephen Edwards: Commercial and Managing Director PhD Industrial Biotechnology, Knowledge Transfer Manager Professor Mathew Brown:"

Similar presentations


Ads by Google